Healthy living

Diseases and chronic disorders related to our lifestyle are on the increase. We must, therefore, look at health and care in a different way, and combine prevention and treatment. At TNO, we’re working on social and technological innovations that help people make choices for better health and greater participation in society.

Promoting health with innovations for self-determination

‘We want to help people make the right choices for their health, employability, and productivity. It's not easy when you see what we have to deal with every day. For example, working longer in a healthy way, an often busy or intense living environment, and an intensive lifestyle,’ says TNO's Peter van Dijken.

Together with government agencies, knowledge institutes, and companies, we develop technological and social innovations that improve health and professional employability. In this way, they contribute to:

  • a healthy, vital, and productive population
  • lower healthcare costs
  • more economic growth

Healthy Living active in 6 domains

The Healthy Living unit is active within 6 expertise groups:

  1. Risk Analysis for Products In Development (RAPID)
  2. Microbiology & Systems Biology Expertise Group
  3. Metabolic Health Research Expertise Group
  4. Child Health Expertise Group
  5. Work Health Technology Expertise Group
  6. Sustainable Productivity & Employability

We’re good at identifying major future developments and interventions relevant to these domains. Within the domains, we develop knowledge and expertise in health, health technology, and customised health interventions. Health interventions are methods and technologies that can be used when someone's health is at risk.

For example, we’re contributing to the transformation of youth healthcare through digitalisation. We’re developing an online platform that provides guidelines for youth healthcare and gives parents access to the professionals and advice they need to make the right choices. In addition, we measure and monitor stress and exposure to harmful substances in everyday life.

This leads us to collective public health strategies, personalised intervention strategies, and evidence-based health interventions, especially for the work environment. This creates a basis for interventions and assistive technology to improve both prevention and participation.

Health interventions

We want to significantly reduce the failure rate and thus the development costs of much-needed new drugs. We do this by innovating in the preclinical and clinical phases of drug development.

We also help the general public and professionals make healthy choices by collecting data on health and risks at a personal level. We convert them into valuable information, which we use to provide proactive, tailor-made advice. This personal information supports structural behavioural changes and a healthier lifestyle. We’re convinced that a change in lifestyle is the cure of the future for many diseases.

How do we improve the quality of digital healthcare?

Healthcare is digitalising at a rapid pace. This allows you to collect a lot of data and gain insight into genetic, lifestyle, and environmental factors. We develop useful, safe, and reliable applications that meet everyone's need for personalised healthcare. Privacy is a prerequisite.

We develop interpretations and predictive models of the personal health data for reliable advice and personalised interventions. We’re trying to improve personalised digital health with practical pilots.

Expert groups

Get inspired

65 resultaten, getoond 1 t/m 5

TNO helps accelerate drug development through insight

Informatietype:
Insight
14 November 2022

To find the most effective interventions for complex metabolic diseases, we must first understand the dynamics of disease onset and progression. Only then can key targets and optimal therapeutic windows for more effective treatment be defined. We spoke with Anita van den Hoek, Research Scientist for TNO Metabolic Health, about how TNO helps pharmaceutical companies accelerate drug development through better understanding of disease pathways.

TNO proves method for effective pediatric drug development

Informatietype:
Insight
14 November 2022

Safe and effective drug dosing for young children come with their own challenges. Up to the age of 18, a child’s metabolism can change significantly. And in the first two years of life, those ontogenic differences can be rapid and dramatic. TNO published its findings from the first drug disposition (mass balance/metabolite profiling) study to conclusively prove that microtracing with accelerator mass spectrometry (AMS) is an effective way to collect clinical data in these young patients. This AMS technology can also be the key to building up more data on drug interventions in pregnant and lactating mothers.

TNO's view of 2030: 50% reduction in lifestyle-related diseases

Informatietype:
Insight
14 November 2022

We look ahead to 2030 and find out, among other things, how we can offer people a healthy environment and with a healthier lifestyle.

International Centering-Based Group Care Conference

Informatietype:
Event

The Centering Netherlands Foundation organizes an Experience Event on Centering-Based Group Care worldwide, in cooperation with TNO, Group Care Global, and the GC_1000 Consortium. Don’t miss this exciting interactive maternal & child health care event where (scientific) knowledge, innovations and experiences of Group Care start up, implementation and development will be shared.

Startdatum:
-
Locatie:
Apenheul – Apeldoorn, the Netherlands

Lifestyle related diseases

Informatietype:
Article

Behavioural change is the key to curing lifestyle diseases. In short: lifestyle as medicine. Find out more about our innovations and tools.